Annual CFI
-$587.77 M
-$587.15 M-94094.55%
31 December 2023
Summary:
Summit Therapeutics annual cash flow from investing activities is currently -$587.77 million, with the most recent change of -$587.15 million (-94094.55%) on 31 December 2023. During the last 3 years, it has fallen by -$587.47 million (-191983.01%). SMMT annual CFI is now -39675.41% below its all-time high of $1.49 million, reached on 31 January 2006.SMMT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$108.61 M
+$91.46 M+45.71%
30 September 2024
Summary:
Summit Therapeutics quarterly cash flow from investing activities is currently -$108.61 million, with the most recent change of +$91.46 million (+45.71%) on 30 September 2024. Over the past year, it has dropped by -$169.18 million (-279.33%). SMMT quarterly CFI is now -279.33% below its all-time high of $60.57 million, reached on 31 December 2023.SMMT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$228.25 M
-$105.13 M-85.38%
30 September 2024
Summary:
Summit Therapeutics TTM cash flow from investing activities is currently -$228.25 million, with the most recent change of -$105.13 million (-85.38%) on 30 September 2024. Over the past year, it has increased by +$359.52 million (+61.17%). SMMT TTM CFI is now -395.82% below its all-time high of $77.16 million, reached on 31 March 2024.SMMT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SMMT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -279.3% | +61.2% |
| 3 y3 years | -10000.0% | -10000.0% | -10000.0% |
| 5 y5 years | -10000.0% | -10000.0% | -10000.0% |
SMMT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -279.3% | +83.2% | -395.8% | +64.8% |
| 5 y | 5 years | <-9999.0% | at low | -279.3% | +83.2% | -395.8% | +64.8% |
| alltime | all time | <-9999.0% | at low | -279.3% | +83.2% | -395.8% | +64.8% |
Summit Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$108.61 M(-45.7%) | -$228.25 M(+85.4%) |
| June 2024 | - | -$200.08 M(-1106.9%) | -$123.13 M(-259.6%) |
| Mar 2024 | - | $19.87 M(-67.2%) | $77.16 M(-113.1%) |
| Dec 2023 | -$587.77 M(>+9900.0%) | $60.57 M(-1837.5%) | -$587.77 M(-9.3%) |
| Sept 2023 | - | -$3.49 M(-1784.1%) | -$648.33 M(+0.5%) |
| June 2023 | - | $207.00 K(-100.0%) | -$644.83 M(-0.1%) |
| Mar 2023 | - | -$645.06 M(<-9900.0%) | -$645.33 M(>+9900.0%) |
| Dec 2022 | -$624.00 K(+103.9%) | $10.00 K(-50.0%) | -$624.00 K(-17.2%) |
| Sept 2022 | - | $20.00 K(-106.8%) | -$754.00 K(-2.1%) |
| June 2022 | - | -$293.00 K(-18.8%) | -$770.00 K(+22.6%) |
| Mar 2022 | - | -$361.00 K(+200.8%) | -$628.00 K(+105.2%) |
| Dec 2021 | -$306.00 K(-27.3%) | -$120.00 K(-3100.0%) | -$306.00 K(+29.7%) |
| Sept 2021 | - | $4000.00(-102.6%) | -$236.00 K(-16.9%) |
| June 2021 | - | -$151.00 K(+287.2%) | -$284.00 K(+6.8%) |
| Mar 2021 | - | -$39.00 K(-22.0%) | -$266.00 K(-36.8%) |
| Dec 2020 | -$421.00 K(+23.5%) | - | - |
| Dec 2020 | - | -$50.00 K(+13.6%) | -$421.00 K(+13.5%) |
| Sept 2020 | - | -$44.00 K(-66.9%) | -$371.00 K(+3.1%) |
| June 2020 | - | -$133.00 K(-31.4%) | -$359.80 K(-26.1%) |
| Mar 2020 | - | -$194.00 K(+491.5%) | -$486.90 K(-11.9%) |
| Dec 2019 | -$341.00 K(+3.0%) | - | - |
| Oct 2019 | - | -$32.80 K(-87.4%) | -$552.80 K(+5.5%) |
| July 2019 | - | -$260.10 K(>+9900.0%) | -$524.10 K(+78.4%) |
| Apr 2019 | - | -$2600.00(-99.0%) | -$293.70 K(-11.3%) |
| Jan 2019 | -$331.00 K(-95.5%) | - | - |
| Jan 2019 | - | -$257.30 K(+6175.6%) | -$331.00 K(-95.3%) |
| Oct 2018 | - | -$4100.00(-86.2%) | -$6.97 M(-0.7%) |
| July 2018 | - | -$29.70 K(-25.6%) | -$7.02 M(-1.1%) |
| Apr 2018 | - | -$39.90 K | -$7.10 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2018 | -$7.42 M(+7319.9%) | - | - |
| Jan 2018 | - | -$6.90 M(>+9900.0%) | -$7.42 M(+1181.1%) |
| Oct 2017 | - | -$56.60 K(-46.5%) | -$579.20 K(+8.0%) |
| July 2017 | - | -$105.80 K(-70.7%) | -$536.20 K(+17.9%) |
| Apr 2017 | - | -$360.80 K(+544.3%) | -$454.90 K(+355.4%) |
| Jan 2017 | -$100.00 K(+94.9%) | - | - |
| Jan 2017 | - | -$56.00 K(+311.8%) | -$99.90 K(+142.5%) |
| Oct 2016 | - | -$13.60 K(-44.5%) | -$41.20 K(-40.4%) |
| July 2016 | - | -$24.50 K(+322.4%) | -$69.10 K(+65.7%) |
| Apr 2016 | - | -$5800.00(-314.8%) | -$41.70 K(-18.7%) |
| Jan 2016 | -$51.30 K(-312.9%) | - | - |
| Jan 2016 | - | $2700.00(-106.5%) | -$51.30 K(-12.6%) |
| Oct 2015 | - | -$41.50 K(-1531.0%) | -$58.70 K(+1530.6%) |
| July 2015 | - | $2900.00(-118.8%) | -$3600.00(-117.6%) |
| Apr 2015 | - | -$15.40 K(+227.7%) | $20.50 K(-14.9%) |
| Jan 2015 | $24.10 K(-77.2%) | - | - |
| Jan 2015 | - | -$4700.00(-134.6%) | $24.10 K(-16.3%) |
| Oct 2014 | - | $13.60 K(-49.6%) | $28.80 K(+89.5%) |
| July 2014 | - | $27.00 K(-328.8%) | $15.20 K(-228.8%) |
| Apr 2014 | - | -$11.80 K | -$11.80 K |
| Jan 2014 | $105.60 K(-202.8%) | - | - |
| Jan 2013 | -$102.70 K(-40.5%) | - | - |
| Jan 2012 | -$172.70 K(+1.1%) | - | - |
| Jan 2011 | -$170.90 K(+48.6%) | - | - |
| Jan 2010 | -$115.00 K(-90.5%) | - | - |
| Jan 2009 | -$1.22 M(-19.8%) | - | - |
| Jan 2008 | -$1.52 M(-34.8%) | - | - |
| Jan 2007 | -$2.32 M(-256.4%) | - | - |
| Jan 2006 | $1.49 M(-105.7%) | - | - |
| Jan 2005 | -$26.00 M | - | - |
FAQ
- What is Summit Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Summit Therapeutics?
- What is Summit Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Summit Therapeutics?
- What is Summit Therapeutics quarterly CFI year-on-year change?
- What is Summit Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Summit Therapeutics?
- What is Summit Therapeutics TTM CFI year-on-year change?
What is Summit Therapeutics annual cash flow from investing activities?
The current annual CFI of SMMT is -$587.77 M
What is the all time high annual CFI for Summit Therapeutics?
Summit Therapeutics all-time high annual cash flow from investing activities is $1.49 M
What is Summit Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SMMT is -$108.61 M
What is the all time high quarterly CFI for Summit Therapeutics?
Summit Therapeutics all-time high quarterly cash flow from investing activities is $60.57 M
What is Summit Therapeutics quarterly CFI year-on-year change?
Over the past year, SMMT quarterly cash flow from investing activities has changed by -$169.18 M (-279.33%)
What is Summit Therapeutics TTM cash flow from investing activities?
The current TTM CFI of SMMT is -$228.25 M
What is the all time high TTM CFI for Summit Therapeutics?
Summit Therapeutics all-time high TTM cash flow from investing activities is $77.16 M
What is Summit Therapeutics TTM CFI year-on-year change?
Over the past year, SMMT TTM cash flow from investing activities has changed by +$359.52 M (+61.17%)